+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review

1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The publisher's summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Les Laboratoires Servier SAS (Servier) researches, develops, manufactures, and markets drugs for treating various diseases. The company's portfolio of marketed products treats central nervous system (CNS) disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, hematological disorders, hormonal disorders, and others. It invests a substantial amount of revenue in R&D. Servier operates research centers in France and Hungary; and International Centers for Therapeutic Research (ICTRs). The company also provides generic drugs and contract development and manufacturing services across its global network. The company also provides digital therapeutic solutions through its e-health division, WeHealth Digital Medicine. It sells products in Europe, America, Middle East, Africa, and Asia. Servier headquartered in Suresnes, France

Les Laboratoires Servier SAS Key Recent Developments

Dec 15, 2022: OPM and Servier launch "FederAidd", an international virtual campus for open innovation to accelerate and make the drug discovery process more reliable thanks to Artificial Intelligence
Dec 14, 2022: Servier joins forces with Gustave Roussy to develop research programs in oncology
Oct 12, 2022: Servier and HealthTech For Care, a shared commitment to accelerate therapeutic innovation
Oct 06, 2022: Servier unveils its 2030 ambition and reveals a new visual identity

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Les Laboratoires Servier SAS - Key Facts
  • Les Laboratoires Servier SAS - Key Employees
  • Les Laboratoires Servier SAS - Key Employee Biographies
  • Les Laboratoires Servier SAS - Major Products and Services
  • Les Laboratoires Servier SAS - History
  • Les Laboratoires Servier SAS - Company Statement
  • Les Laboratoires Servier SAS - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Les Laboratoires Servier SAS - Business Description
  • Product Category: Branded Medicines
  • Performance
  • Product Category: Generic Medicines
  • Performance
  • Geographical Segment: Africa and Middle East
  • Performance
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: Asia and Oceania
  • Performance
  • Geographical Segment: Europe (Outside the EU)
  • Performance
  • Geographical Segment: European Union
  • Performance
  • Les Laboratoires Servier SAS - SWOT Analysis
  • SWOT Analysis - Overview
  • Les Laboratoires Servier SAS - Strengths
  • Les Laboratoires Servier SAS - Weaknesses
  • Les Laboratoires Servier SAS - Opportunities
  • Les Laboratoires Servier SAS - Threats
  • Les Laboratoires Servier SAS - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Les Laboratoires Servier SAS, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Dec 15, 2022: OPM and Servier launch"FederAidd", an international virtual campus for open innovation to accelerate and make the drug discovery process more reliable thanks to Artificial Intelligence
  • Dec 14, 2022: Servier joins forces with Gustave Roussy to develop research programs in oncology
  • Oct 12, 2022: Servier and HealthTech For Care, a shared commitment to accelerate therapeutic innovation
  • Oct 06, 2022: Servier unveils its 2030 ambition and reveals a new visual identity
  • Sep 16, 2022: Servier backs a Californian startup research project to accelerate therapeutic innovation
  • Aug 26, 2022: Servier on the front line of cardiovascular disease prevention and therapeutic adherence
  • Jun 23, 2022: Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting
  • Jun 15, 2022: Servier : Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
  • Jun 01, 2022: Patient associations’ perception of pharmaceutical companies: Servier is making progress
  • Apr 27, 2022: Appointment of Walid S. Kamoun, PhD. MSc., Global Head of Servier R&D Oncology
Section 5 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Les Laboratoires Servier SAS, Key Facts
  • Les Laboratoires Servier SAS, Key Employees
  • Les Laboratoires Servier SAS, Key Employee Biographies
  • Les Laboratoires Servier SAS, Major Products and Services
  • Les Laboratoires Servier SAS, History
  • Les Laboratoires Servier SAS, Subsidiaries
  • Les Laboratoires Servier SAS, Key Competitors
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Les Laboratoires Servier SAS, Recent Deals Summary
List of Figures
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned

A selection of companies mentioned in this report includes:

  • NicOx SA
  • Laboratoires Pierre Fabre SA
  • Inato
  • Sanofi
  • Pfizer Inc
  • Laboratoires Thea SA
  • Ipsen SA